What is the role of topical agents in the treatment of basal cell carcinoma (BCC)?

Updated: Mar 02, 2020
  • Author: Robert S Bader, MD; Chief Editor: William D James, MD  more...
  • Print

Topical agents used in the treatment of superficial BCC include the following [7] :

  • Topical 5-fluorouracil 5%: May be used to treat small, superficial BCCs in low-risk areas

  • Imiquimod: Approved by the US Food and Drug Administration (FDA) for the treatment of nonfacial superficial BCC

  • Tazarotene: Can also be used to treat small, low-risk BCCs

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!